emochromatosis is a systemic disease known as 'iron storage disease' and has been classified as idiopathic or secondary. Most patients diagnosed with secondary hemochromatosis have had repeated blood transfusions. Cardiac failure is the cause of death in onethird of patients with hemochromatosis. Liver dysfunction or endocrine disorders, such as diabetes, generally appear prior to cardiac failure, but there are a few reported cases that showed cardiac dysfunction without liver cirrhosis.
We report here such a patient with secondary hemochromatosis predominantly causing cardiac dysfunction without any signs or symptoms of liver cirrhosis clinically and without a history of repeated blood transfusions.
Case Report
A 23-year-old woman was found to have congenital nonspherocytic hemolytic anemia at 8 years of age (laboratory results showed no morphologic or enzymatic abnormalities of erythrocytes). She had no history of iron therapy and had undergone partial splenic arterial embolization 2 years ago at age 21 years. However, this treatment was not completely effective, and 4 months prior to the current investigation splenectomy was performed, with simultaneous cholecystectomy for gallstones. She received only 2 units of packed red blood cells at this time.
Four months after surgery, the patient developed congestive heart failure (CHF), which presented as a dry cough, dyspnea on exertion, pretibial edema, and weight gain. For the past 4 years she reported being amenorrheic. Her parents were alive and apparently healthy.
Examination of her skin revealed jaundice, but no iron pigmentation. Her conjunctivae were pale. The patient had a funnel chest and scoliosis, and a systolic ejection murmur was audible at the apex. Her liver was enlarged, with a 7 cm span below the right costal margin on the midclavicular line, and bilateral trace pedal edema was present. Chest radiographs showed cardiomegaly with a cardiothoracic ratio of 71% and mild pulmonary congestion. Her resting electrocardiogram revealed inverted T waves in leads II, III, aVF, and V2-6. Her hemoglobin level was 8.2 g/dl; her serum ferritin level was markedly elevated (3161.5 ng/ml); serum iron was 154 g/dl; total bilirubin level was 3.1 mg/dl; indirect To further assess the etiology of her CHF, cardiac catheterization and endomyocardial heart biopsy were performed.
Coronary arteries were normal on coronary angiography. Moderate to severe hypokinesis of the left ventricular wall, especially of the inferior wall, was found; left ventricular ejection fraction 42% and cardiac index 3.4 L·min -1 ·m -2 . Right cardiac catheterization showed a mildly elevated pulmonary arterial pressure of 32/11 mmHg. Microscopic examination of the right ventricuar endomyocardial biopsy showed enlarged myocytes containing many pigmented granules highlighted by the Prussian blue reaction. There was no histologic evidence of inflammation (Fig 1) .
Desferoxamine was given subcutaneously (10 mg/kg), and her urinary iron was markedly elevated to 15.3 mg/day, which suggested systemic iron deposition. Abdominal ultrasonography revealed a dull-edged liver and hepatomegaly; however, the liver's surface was smooth. Thoracic computed tomography (CT) revealed high-density values in the heart (48-50 Hounsfield units) and liver (86 HU) (Fig 2A,B) . Using magnetic resonance imaging, low signal intensities were noted in the myocardium and the liver (Fig 2C) , suggesting that iron deposition was also present in the liver. A diagnosis of cardiac hemochromatosis was made. Because the patient had anemia as a result of the hemolysis, phlebotomy therapy was not indicated. Therefore, she was treated for the CHF and given desferoxamine intravenously as an outpatient.
Discussion
Although the present patient had congenital non-spherocytic hemolytic anemia, her hemoglobin level ranged from 8 to 10 g/dl and her total bilirubin level was approximately 5.0 mg/dl for 20 years. Prior to the current hospitalization the patient had undergone both partial splenic arterial embolization and splenectomy. During the present admission, her viral serologic tests were negative and there was no morphologic evidence of myocarditis on histologic examination. As coronary angiography showed her coronary arteries to be free of disease, cardiac hemochromatosis was diagnosed as the primary cause of her CHF. 1, 2 Hemochromatosis is classified as primary or secondary. Primary hemochromatosis is an autosomal recessive disorder, whereas secondary hemochromatosis is the result of iron overload, usually from repeated transfusions, hemolysis or alcoholic liver injury. In this case, the patient had received only 2 units of packed red blood cells, but she had a long history of congenital hemolytic anemia; her urinary iron was markedly raised to 15.3 mg/day by administration of desferoxamine (10 mg/kg); hepatomegaly was present; 3 her liver had abnormal densities on CT and MRI; and, an endomyocardial biopsy revealed deposits of hemosiderin in myocytes. For these reasons CHF secondary to hemochromatosis was diagnosed. 4 It was compatible with this disease that her plasma ferritin level was high, and her unsaturated iron binding capacity was low. 5 It seems probable that the hemochromatosis caused her amenorrhea, impaired glucose tolerance.
The most common physical findings of hemochromatosis are hepatomegaly in 93-99%, secondary diabetes mellitus in 59-82% and disorders of sexual development in 6-87%. 6, 7 Left ventricular dysfunction, which occurs in 35-60% of patients usually appears later. 8, 9 It is said that liver, which is the first organ damaged in idiopathic hemochromatosis, is almost always firm and enlarged, having an average weight of 2,500 g. However, the present patient did not have clinical liver cirrhosis; asparate aminotransferase, alanine aminotransferase and prothrombin time were all normal as well as other pertinent laboratory data. As shown by abdominal ultrasonography, hepatomegaly was present, but the liver surface was smooth, which suggested that there was no clinical liver cirrhosis on admission.
Though cardiac death from this disease occurs in onethird of patients, the mechanisms by which disordered iron metabolism gives rise to impaired myocardial function are not yet fully resolved. French investigators have suggested that heart failure is caused by endocrine disturbances as 'Syndrome endocrino-cardiaque'. 10, 11 Other authors report that it is a result of pigment deposition. 12 And some reports interpreted lysosome dysfunction as the cause of cardiac failure. 13 Microsomal lipid peroxidation can cause myocardial function to deteriorate and extreme degree of fatty degeneration of the heart is thought to be a cause of CHF. 14, 15 Most patients with secondary hemochromatosis had iron overload from blood transfusion, and revealed symptoms of CHF after other organic damage, as liver cirrhosis or diabetes mellitus. 14, [16] [17] [18] [19] The present case is special in some aspects. First, the hemochromatosis was caused by long term congenital nonspherocytic hemolytic anemia without transfusion-related iron overload. Second, the hemochromatosis was not diagnosed by signs of liver cirrhosis or abnormal skin pigmentation, but by symptoms of CHF. Therefore, this case is not primary hemochromatosis and so we diagnosed secondary hemochromatosis caused by congenital non-spherocytic hemolytic anemia. As far as we can ascertain, there is only one other similar report of a case showing symptoms of cardiac failure without liver dysfunction. 20 In conclusion, we have presented a case of secondary hemochromatosis that manifested as CHF as the first clinical symptom and was caused by congenital non-spherocytic hemolytic anemia without repeated blood transfusion.
